Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,414,629
+$10,414,632 QoQ
Shares Held
6,694,637
+0.4% QoQ
Ownership
4.55%
of shares outstanding
% of Portfolio
3.35%
of 13F equity value
Holder Rank
#5
of 149 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vivo Capital, LLC holds $1,052,388,129 across 43 Biotechnology names. ACRS ranks #10 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
5,094,668 | $95,015,558 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
271,116 | $90,766,925 | |
| 3 | ERAS |
Erasca, Inc.
|
4,127,412 | $75,614,187 | |
| 4 | AVBP |
ArriVent BioPharma, Inc.
|
1,682,097 | $58,436,049 | |
| 5 | ABVX |
Abivax S.A.
|
414,899 | $55,289,440 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
1,379,769 | $43,131,578 | |
| 7 | CRVS |
Corvus Pharmaceuticals, Inc.
|
2,805,816 | $41,918,891 | |
| 8 | DRUG |
Bright Minds Biosciences Inc.
|
557,172 | $39,113,474 |
All Filings in ACRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,414,629 | 6,694,637 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,999,997 | 6,666,666 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $26,755,552 | 8,888,888 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,888,887 | 8,888,888 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,622,220 | 8,888,888 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $13,599,998 | 8,888,888 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $22,044,442 | 8,888,888 | Shares | Sole | 2025-02-13 | |
| 2023-09-30 | $6,155,622 | 898,631 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,318,803 | 898,631 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,269,924 | 898,631 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,153,438 | 898,631 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $14,144,451 | 898,631 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,544,888 | 898,631 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $15,492,398 | 898,631 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $13,391,078 | 920,982 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $16,933,572 | 940,754 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $24,132,339 | 1,374,279 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $41,509,792 | 1,647,214 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,657,474 | 1,647,214 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,233,339 | 1,647,214 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,668,486 | 1,647,214 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $1,713,102 | 1,647,214 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||